Cagrilintide vs Tesamorelin.
Quick Verdict
Cagrilintide is a metabolic primarily researched for weight loss, appetite reduction, glycemic control, while Tesamorelin is a ghrh analog studied for visceral fat reduction, body recomposition. A key distinction: Tesamorelin has FDA approval status.
Side-by-Side Analysis
| Dimension | Cagrilintide | Tesamorelin |
|---|---|---|
| Category | Metabolic | GHRH Analog |
| Mechanism | Long-acting amylin analog that activates amylin receptors in the area postrema and hypothalamus to reduce appetite, slow gastric emptying, and suppress post-meal glucagon secretion. | Stimulates GH for fat metabolism. |
| Half-Life | ~7 days | ~26 minutes |
| Route | SubQ | SubQ |
| Typical Dose | 500–4500 mcg | 1000–1000 mcg |
| Frequency | Weekly | 7x/week |
| Evidence Level | Strong | Very Strong |
| Indexed Studies | 20+ indexed | 20+ indexed |
| FDA Status | Research Only | Approved |
| Lowest Price | $69.99 / 10mg via Amino Club | $69.99 / 10mg via Amino Club |
| Per-mg Cost | $7.00/mg | $7.00/mg |
Mechanism of Action Comparison
How Cagrilintide Works
Cagrilintide Cagrilintide is a long-acting amylin analog investigated for weight loss, studied in Phase 2 trials for achieving over 10% body weight reduction when combined with semaglutide.
Long-acting amylin analog that activates amylin receptors in the area postrema and hypothalamus to reduce appetite, slow gastric emptying, and suppress post-meal glucagon secretion. Works on a distinct pathway from GLP-1 agonists, making it ideal for combination therapy.
How Tesamorelin Works
Tesamorelin Tesamorelin is the only FDA-approved growth-hormone-releasing peptide (Egrifta) indicated specifically for reducing visceral abdominal fat in HIV-associated lipodystrophy.
Stimulates GH for fat metabolism. Binds to GHRH receptors on the pituitary gland to stimulate natural growth hormone production, specifically targeting visceral adipose tissue.
Key Mechanistic Difference
Cagrilintide operates as a metabolic, while Tesamorelin functions as a ghrh analog — these are fundamentally different pharmacological approaches. Cagrilintide has a significantly longer half-life (~7 days) compared to Tesamorelin (~26 minutes), which impacts dosing frequency and sustained activity.
Research Evidence
Cagrilintide
20 studies- Cagrilintide Phase 2 trial for weight managementLau et al. (Lancet): Phase 2 RCT showing cagrilintide 4.5mg weekly achieved 10.8% weight loss vs 3.0% placebo at 26 week…Strong
- CagriSema (cagrilintide + semaglutide) Phase 2 resultsFrias et al. (Lancet): CagriSema combination achieved 15.6% weight loss at 32 weeks in type 2 diabetes patients — superi…Strong
- Amylin analogs in obesity management: mechanism reviewReview of amylin's role in energy homeostasis and why dual amylin-calcitonin receptor agonists like cagrilintide represe…Moderate
Tesamorelin
20 studies- Tesamorelin visceral fat reduction (FDA trial)Falutz et al. (JAMA): Randomized, double-blind, placebo-controlled Phase 3 trial showing 15.2% reduction in visceral adi…Very Strong
- Tesamorelin 52-week extension study sustained VAT reductionFalutz et al. (J. Clin. Endocrinol. Metab.): 52-week data confirming sustained 18% visceral fat reduction with continuou…Strong
- Tesamorelin reduces liver fat in HIV lipodystrophyStanley et al. (Ann. Intern. Med.): RCT demonstrating tesamorelin reduces hepatic fat content in HIV-infected patients w…Strong
Vendor Pricing
· Affiliate links · Prices verified 2026Cagrilintide
2 vendorsAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Can I take Cagrilintide and Tesamorelin together?▼
No direct interaction data is available for this specific pair. They target different receptor systems, suggesting they could potentially be combined, but no published protocol validates this combination.
Which has more research evidence — Cagrilintide or Tesamorelin?▼
Cagrilintide has 20 indexed studies (highest evidence: Strong). Tesamorelin has 20 indexed studies (highest evidence: Very Strong). Both have comparable research coverage.
What is the price difference between Cagrilintide and Tesamorelin?▼
At current verified vendor prices, Tesamorelin starts at $7.00/mg while Cagrilintide starts at $7.00/mg. Prices vary by vendor and vial size — see the full vendor comparison below.
Which is better for fat loss — Cagrilintide or Tesamorelin?▼
Both are researched for fat loss. Cagrilintide addresses this via weight loss, appetite reduction, glycemic control. Tesamorelin approaches it through visceral fat reduction, body recomposition. The optimal choice depends on your specific research protocol and which mechanism aligns with your objectives.
Is Cagrilintide or Tesamorelin FDA-approved?▼
Tesamorelin has FDA approval (or is derived from an FDA-approved compound). Cagrilintide is a research compound without FDA approval for human use. FDA status reflects regulatory evaluation — not necessarily superiority for all research applications.
Related Comparisons
Deep Dive Profiles
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.